Lv1
60 积分 2026-06-29 加入
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial
10小时前
已完结
CBX8 promotes lung adenocarcinoma growth and metastasis through transcriptional repression of CDKN2C and SCEL
2个月前
已完结
PARD6A promotes lung adenocarcinoma cell proliferation and invasion through Serpina3
2个月前
已完结
皖公网安备34019202002308
